Your browser doesn't support javascript.
loading
Lifetime Risk Factors for Pre- and Post-Bronchodilator Lung Function Decline. A Population-based Study.
Bui, Dinh S; Perret, Jennifer L; Walters, E Haydn; Abramson, Michael J; Burgess, John A; Bui, Minh Q; Bowatte, Gayan; Lowe, Adrian J; Russell, Melissa A; Alif, Sheikh M; Thompson, Bruce R; Hamilton, Garun S; Giles, Graham G; Thomas, Paul S; Morrison, Stephen; Johns, David P; Knibbs, Luke D; Zock, Jan-Paul; Marcon, Alessandro; Garcia-Aymerich, Judith; Erbas, Bircan; Jarvis, Deborah; Svanes, Cecilie; Lodge, Caroline J; Dharmage, Shyamali C.
Afiliação
  • Bui DS; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Perret JL; Department of Analytical Chemistry and Toxicology, Hanoi University of Pharmacy, Hanoi, Vietnam.
  • Walters EH; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Abramson MJ; Institute for Breathing and Sleep, Heidelberg, Melbourne, Victoria, Australia.
  • Burgess JA; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Bui MQ; School of Public Health and Preventive Medicine.
  • Bowatte G; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Lowe AJ; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Russell MA; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Alif SM; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Thompson BR; Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia.
  • Hamilton GS; School of Public Health and Preventive Medicine.
  • Giles GG; Central Clinical School.
  • Thomas PS; Allergy, Immunology, and Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Morrison S; School of Clinical Sciences, and.
  • Johns DP; Monash Lung and Sleep, Monash Health, Melbourne, Victoria, Australia.
  • Knibbs LD; Precision Medicine, School of Clinical Sciences at Monash Health, Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Zock JP; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Marcon A; Prince of Wales Hospital Clinical School and School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • Garcia-Aymerich J; University of Queensland, Brisbane, Queensland, Australia.
  • Erbas B; Department of Respiratory Medicine, School of Medicine, Flinders University, Adelaide, South Australia, Australia.
  • Jarvis D; School of Public Health, the University of Queensland, Brisbane, Queensland, Australia.
  • Svanes C; ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Lodge CJ; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Dharmage SC; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
Ann Am Thorac Soc ; 17(3): 302-312, 2020 03.
Article em En | MEDLINE | ID: mdl-31800292
ABSTRACT
Rationale Interactions between early life and adult insults on lung function decline are not well understood, with most studies investigating prebronchodilator (pre-BD) FEV1 decline.

Objectives:

To investigate relationships between adult risk factors and pre- and post-BD lung function decline and their potential effect modification by early life and genetic factors.

Methods:

Multiple regression was used to examine associations between adult exposures (asthma, smoking, occupational exposures, traffic pollution, and obesity) and decline in both pre- and post-BD spirometry (forced expiratory volume in 1 s [FEV1], forced vital capacity [FVC], and FEV1/FVC) between ages 45 and 53 years in the Tasmanian Longitudinal Health Study (n = 857). Effect modification of these relationships by childhood respiratory risk factors, including low childhood lung function and GST (glutathione S-transferase) gene polymorphisms, was investigated.

Results:

Baseline asthma, smoking, occupational exposure to vapors/gases/dusts/fumes, and living close to traffic were associated with accelerated decline in both pre- and post-BD FEV1. These factors were also associated with FEV1/FVC decline. Occupational exposure to aromatic solvents was associated with pre-BD but not post-BD FEV1 decline. Maternal smoking accentuated the effect of personal smoking on pre- and post-BD FEV1 decline. Lower childhood lung function and having the GSTM1 null allele accentuated the effect of occupational exposure to vapors/gases/dusts/fumes and personal smoking on post-BD FEV1 decline. Incident obesity was associated with accelerated decline in FEV1 and more pronounced in FVC.

Conclusions:

This study provides new evidence for accentuation of individual susceptibility to adult risk factors by low childhood lung function, GSTM1 genotype, and maternal smoking.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Capacidade Vital / Volume Expiratório Forçado / Exposição Ocupacional / Pulmão / Pneumopatias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Capacidade Vital / Volume Expiratório Forçado / Exposição Ocupacional / Pulmão / Pneumopatias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article